368 related articles for article (PubMed ID: 4683093)
1. L-dopa for parkinsonism.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
[No Abstract] [Full Text] [Related]
2. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
3. [Results of treatment of Parkinsonism with L-dopa].
De Divitiis E; D'Andrea F; Signorelli CD
Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
[No Abstract] [Full Text] [Related]
4. Failures of L-dopa.
Paulson GW
Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
[No Abstract] [Full Text] [Related]
5. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
Antonini F; Baroni A; Roveyaz L
Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
[No Abstract] [Full Text] [Related]
6. Levodopa and amantadine in the treatment of Parkinsonism.
Critchley E
Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
[No Abstract] [Full Text] [Related]
7. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
Almici GM; Sbarbaro V
Minerva Med; 1974 Feb; 65(8):398-401. PubMed ID: 4820722
[No Abstract] [Full Text] [Related]
8. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
Rosati G; Agnetti V; Mura F; Granieri E
Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
[No Abstract] [Full Text] [Related]
9. [10 years of L-DOPA therapy of Parkinson's syndrome].
Birkmayer W
Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
[No Abstract] [Full Text] [Related]
10. Treatment of parkinsonism with levo-dopa: results in 302 cases.
Newkirk TA; Magee KR
Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
[No Abstract] [Full Text] [Related]
11. [Problems and therapy of L-DOPA-induced dyskinesias].
Völler GW; Deze J; Gundlach U; Muschard F
Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
[No Abstract] [Full Text] [Related]
12. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
13. Parkinson's disease treated with L-dopa. Three-year follow-up report.
Mones RJ
N Y State J Med; 1972 Nov; 72(22):2749-50. PubMed ID: 4510706
[No Abstract] [Full Text] [Related]
14. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
[No Abstract] [Full Text] [Related]
15. Side effects of L-dopa treatment.
Greenburg J
Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645
[No Abstract] [Full Text] [Related]
16. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
Kuran W
Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001
[No Abstract] [Full Text] [Related]
17. [Clinical study of L-dopa in Parkinson's disease].
Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
[No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
[No Abstract] [Full Text] [Related]
19. The treatment of parkinsonism with L-Dopa and amantadine.
Green J
J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
[No Abstract] [Full Text] [Related]
20. L-dopa and amantadine for Parkinsonism.
Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
